These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27633887)

  • 1. The Properties of HPMC:PEO Extended Release Hydrophilic Matrices and their Response to Ionic Environments.
    Hu A; Chen C; Mantle MD; Wolf B; Gladden LF; Rajabi-Siahboomi A; Missaghi S; Mason L; Melia CD
    Pharm Res; 2017 May; 34(5):941-956. PubMed ID: 27633887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Within-Tablet Dynamics for Extended Release of a Poorly Soluble Basic Drug from Hydrophilic Matrix Tablets Using ATR-FTIR Imaging.
    Zahoor FD; Mader KT; Timmins P; Brown J; Sammon C
    Mol Pharm; 2020 Apr; 17(4):1090-1099. PubMed ID: 32069060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and managing the impact of HPMC variability on drug release from controlled release formulations.
    Zhou D; Law D; Reynolds J; Davis L; Smith C; Torres JL; Dave V; Gopinathan N; Hernandez DT; Springman MK; Zhou CC
    J Pharm Sci; 2014 Jun; 103(6):1664-72. PubMed ID: 24652662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
    Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin.
    Tajiri T; Morita S; Sakamoto R; Mimura H; Ozaki Y; Reppas C; Kitamura S
    Int J Pharm; 2015 Jul; 490(1-2):368-74. PubMed ID: 26022889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydrophobic inclusions on polymer swelling kinetics studied by magnetic resonance imaging.
    Gajdošová M; Pěček D; Sarvašová N; Grof Z; Štěpánek F
    Int J Pharm; 2016 Mar; 500(1-2):136-43. PubMed ID: 26780121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
    Nie SF; Liu H; Liu YL; Pan WS
    Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended release of flurbiprofen from tromethamine-buffered HPMC hydrophilic matrix tablets.
    Pygall S; Kujawinski S; Timmins P; Melia C
    Pharm Dev Technol; 2018 Nov; 23(9):874-881. PubMed ID: 28298171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of HPMC substituent pattern on water up-take, polymer and drug release: An experimental and modelling study.
    Caccavo D; Lamberti G; Barba AA; Abrahmsén-Alami S; Viridén A; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):705-713. PubMed ID: 28636894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
    Nie SF; Tang H; Guo H; Pan WS
    Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.